Pharmaceutical products

Tender description

NHS Framework Agreement for the supply of Icatibant and C1 Esterase products for the treatment of Hereditary Angioedema. The Framework Agreement is intended for use by the Department of Health and Social Care, Public Health England and the NHS in England, Scotland, Wales and Northern Ireland. The framework may also be used by private sector contractors and agents working on behalf of the above. The framework will commence on the 1.7.2018 for a period of 12 months until 30.6.2019, with options to extend up to a further 36 months. Please refer to the invitation of Offer documents for the list of Purchasing Points. NHS Framework Agreement for the supply of Icatibant and C1 Esterase products for the treatment of Hereditary Angioedema. The framework agreement is intended for use by the Department of Health and Social Care, Public Health England and the NHS in England, Scotland, Wales and Northern Ireland. The framework may also be used by private sector contractors and agents working on behalf of the above. The framework will commence on the 1.7.2018 for a period of 12 months until 30.6.2019, with options to extend up to a further 36 months. Please refer to the invitation of Offer documents for the list of Purchasing Points.